XM does not provide services to residents of the United States of America.
A
A

Accor

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Adyen, AstraZeneca, Auto Trader

EUROPE RESEARCH ROUNDUP-Adyen, AstraZeneca, Auto Trader July 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen, AstraZeneca and Auto Trader, on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Jefferies cuts target price to EUR 1,695 from EUR 1,821 * AstraZeneca AZN.L : Jefferies raises target price to 11,700p from 11,300p * Auto Trader AUTOA.L : Jefferies raises target price to 935p from 830p * Halma HLMA.L : HSBC raises target pri
3
A
A
A
B
C
C
C
E
E
E
G
H
R
S
S
V
A
A
A
A
A
B
N
N
S

Covivio and AccorInvest sign preliminary agreement on asset-swap deal

UPDATE 1-Covivio and AccorInvest sign preliminary agreement on asset-swap deal Adds valuations and timeline June 21 (Reuters) - Real estate company Covivio CVO.PA has signed a preliminary agreement finalising terms on a proposed asset-swap deal with AccorInvest, it said on Friday. The deal will involve the transfer of 24 hotel operating companies worth 266 million euros ($283.9 million) to Covivio's hotels subsidiary while 10 property companies worth 208 million euros will move in the opposite d
A
C

Covivio and AccorInvest sign MoU to combine their hotel properties

Covivio and AccorInvest sign MoU to combine their hotel properties June 21 (Reuters) - Real estate owner Covivio CVO.PA said on Friday it had signed a memorandum of understanding with its peer AccorInvest ACCP.PA looking to combine their hotel property and operating companies. The deal is expected to close in the final quarter of 2024, Covivio said in a statement.
A
C

Covivio And AccorInvest Sign MoU To Consolidate Hotel Property And Operating Companies

BRIEF-Covivio And AccorInvest Sign MoU To Consolidate Hotel Property And Operating Companies June 21 (Reuters) - Covivio SA CVO.PA : COVIVIO AND ACCORINVEST SIGN A MEMORANDUM OF UNDERSTANDING WITH A VIEW TO CONSOLIDATING THEIR HOTEL PROPERTY AND OPERATING COMPANIES TRANSACTION IS EXPECTED TO CLOSE IN FINAL QUARTER OF 2024 THE AGREED VALUE OF THE PR
A
C

Top of the Street: Accor, Umicore, GEA, Rockwool

BUZZ-Top of the Street: Accor, Umicore, GEA, Rockwool A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays raises French hotel group Accor ACCP.PA to "overweight" from "equal weight", saying the stock's underperformance vs peers over the past year is "unjustified" ** J.P.Morgan double-upgrades Belgian materials technology and recycling group Umicore UMI.BR to "overweight" from "underweight", saying challenges for the battery materials business are un
A
G
J
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.